BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 825846)

  • 1. Preparation and immunosuppressive potency of equine anti-human thymocyte membrane IgG.
    Diethelm AG; Chambers LM; Balch CM; Phillips SJ
    Postgrad Med J; 1976; 52(5 Suppl):55-8. PubMed ID: 825846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preparation and immunosuppressive properties of equine antihuman thymocyte membrane immunoglobulin G.
    Diethelm AG; Chambers L; Sachs G; Balch CM; Phillips SJ; Thiry C
    Surgery; 1979 Feb; 85(2):159-65. PubMed ID: 105416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular basement membrane--reactive antibody in anti-lymphocyte globulin.
    Wilson CB; Dixon FJ; Fortner JG; Cerilli GJ
    J Clin Invest; 1971 Jul; 50(7):1525-35. PubMed ID: 4996886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of in vitro, immunosuppressive and clinical effects of goat and horse anti-human thymocyte globulin in Macaca monkeys.
    Kelly GE; Sheil AG; Mears DC
    Clin Exp Immunol; 1973 Apr; 13(4):585-94. PubMed ID: 4197827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of antilymphocyte globulin by human peripheral lymphocytes.
    Brain P; Marston RH
    Clin Exp Immunol; 1973 Mar; 13(3):423-6. PubMed ID: 4633851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
    Thomas JM; Carver FM; Thomas FT
    Surg Forum; 1979; 30():282-3. PubMed ID: 120017
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of horse-anti-rabbit thymocyte antiserum (ATS) on draining lymph node cells in rabbit. I. Number of cells coated with anti-lymphocytic antibodies.
    Szymaniec S; Bromirska J
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):343-5. PubMed ID: 312070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the activity of antithymocyte serum (ATS), particularly on the relation between its anti-inflammatory and immunosuppressive effects.
    Gieldanowski J; Blaszczyk B; Szymaniec S; Ludwikowska A
    Arch Immunol Ther Exp (Warsz); 1977; 25(3):367-75. PubMed ID: 329800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescent titration of thymocyte reactive membrane antibodies as a suggested in vitro correlate of the immunosuppressive potency of anti-human thymocyte globulin.
    Ablin RJ; Morrell RM
    Eur Surg Res; 1976; 8(2):140-7. PubMed ID: 821756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative effectiveness of rabbit anti-mouse thymocyte sera in potentiating the survival of mouse skin or tumour allografts made across the H-2 barrier.
    Lai T; Symes MO
    Immunology; 1976 Jul; 31(1):21-6. PubMed ID: 800400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole antilymphocyte serum: a potent safe immunosuppressive agent for intravenous use in man.
    Levey RH; Parkman R
    Transplant Proc; 1977 Mar; 9(1):1019-22. PubMed ID: 405764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
    Thomas JM; Carver FM; Burnett CM; Thomas FT
    Transplant Proc; 1981 Mar; 13(1 Pt 1):599-602. PubMed ID: 7022896
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effects of horse ATG and rabbit ATG on T cell and T cell subset levels measured by monoclonal antibodies.
    Thomas FT; Griesedieck C; Thomas J; Carver M; Whitley T; Warren R; Williams D
    Transplant Proc; 1984 Dec; 16(6):1561-3. PubMed ID: 6239426
    [No Abstract]   [Full Text] [Related]  

  • 15. Production and diagnostic application of anti-human T-cell antisera.
    Wick G; Ahmad R; Steiner R; Zeilinger M; Wolner E; Mittermayer K; Stacher A
    Postgrad Med J; 1976; 52(5 Suppl):20-6. PubMed ID: 825844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical factors in the quality control of antilymphocyte globulin (ALG).
    Thomas F; Thomas J; Millington G; Doane J; Mendez-Picon G; Lee HM
    Proc Clin Dial Transplant Forum; 1977; 7():134-40. PubMed ID: 98763
    [No Abstract]   [Full Text] [Related]  

  • 17. Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera.
    Brochier J; Abou-Hamed YA; Gueho JP; Revillard JP
    Immunology; 1976 Nov; 31(5):749-58. PubMed ID: 1086826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful bone marrow transplantation with rabbit anti-human thymocyte globulin in aplastic anemia. Report of a case previously treated with equine anti-human lymphocyte globulin.
    Yoshida Y; Ichinoe T; Dodo M; Noukawa M; Maeda A; Oguma S; Tajima M; Yamamoto K; Okuma M
    Int J Hematol; 1994 Jul; 60(1):79-83. PubMed ID: 7919240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunofluorescent assay of anti-human thymocyte globulin as a means of correlating "in vitro" and "in vivo" activity.
    Ablin RJ; Morrell RM
    Dev Biol Stand; 1974; 27():223-8. PubMed ID: 4618534
    [No Abstract]   [Full Text] [Related]  

  • 20. The sensitizing properties of anti-mouse anti-thymocyte horse serum.
    Osz E; RĂ©thy L
    Ann Immunol Hung; 1975; 18():151-8. PubMed ID: 1088392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.